Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5578529 | Journal of Pain and Symptom Management | 2017 | 25 Pages |
Abstract
This study found a median remaining lifetime of 55Â days after recognition of terminal illness. Remaining lifetime differed between cancer and noncancer patients and according to age and gender. Increased attention should be directed toward timely recognition of the transition into the terminal phase, especially for patients with noncancer disease.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Cathrine MHSc, Mette K. PhD, MD, Mette A. PhD, MD, Mai-Britt PhD, MD, Anders B. PhD, MD,